New targeted treatment approved for children with brain cancer
by The Independent
The Independent— The drugs improve children’s response rate to treatment and survival time without the disease getting worse.
The Independent—New NHS treatment could transform lives of thousands of children with brain tumours. Combination of dabrafenib and trametinib can now be used for patients aged one and over
The Guardian—‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England. Dabrafenib with trametinib can halt growth of some tumours for more than three times as long as standard chemotherapy, study showsThe NHS is to offer children with brain tumours in England a groundbreaking new targeted drug therapy to tackle the disease – a development charities are hailing as the biggest breakthrough in decades.Gliomas are the most common type of brain cancer in children but experts say the standard treatment of chemotherapy can be brutal and gruelling, and also carries the...
Los Angeles Times—FDA approves bladder cancer treatment by Culver City company. The Food and Drug Administration on Monday approved a new treatment for a type of bladder cancer. The treatment, which will be sold under the brand name Anktiva, is intended for some patients suffering from certain types of non-muscle invasive bladder cancer, according to an FDA statement announcing the approval. News of the FDA action was first reported by Reuters, which said, "The therapy works by activating types of disease fighting white blood cells called natural killer (NK) cells and...